Total Funding
42
58
Total FundingSeed raised
Growth Score 42 in past quarter
-5 pts
Heat Score 58 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
70702
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
- Vanessa Malier: Chairman of the BoardPast Role: Nuage Therapeutics, Executive Chairman
About the Company
Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved in
challenging indications in order to meet unmet medical needs.